Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Karyopharm Therapeutics
Biotech
Karyopharm lays off 20% of staffers amid hunt for alternatives
At the end of last year, Karyopharm recorded an accumulated deficit of $1.6 billion, according to an annual report.
Gabrielle Masson
Jul 11, 2025 11:02am
Vincerx acquisition leads to C-suite shake-up—Chutes & Ladders
Jan 3, 2025 8:30am
Biogen takes nuclear option, terminating Karyopharm ALS pact
Jun 16, 2022 8:25am
John Mascola moves on from NIAID's R&D hub—Chutes and Ladders
Apr 1, 2022 9:30am
Karyopharm snags former Merck exec as chief medical officer
Mar 29, 2022 2:34pm
New discoveries in immuno-oncology and diabetes—News of note
Dec 9, 2019 11:00am
